Cell cycle checkpoints and their inactivation in human cancer
- PMID: 11063129
- PMCID: PMC6496592
- DOI: 10.1046/j.1365-2184.2000.00191.x
Cell cycle checkpoints and their inactivation in human cancer
Abstract
Checkpoints are mechanisms that regulate progression through the cell cycle insuring that each step takes place only once and in the right sequence. Mutations of checkpoint proteins are frequent in all types of cancer as defects in cell cycle control can lead to genetic instability. This review will focus on three major areas of cell cycle transition control, with particular attention to the alterations found in human cancer. These areas include the G1/S transition, where most cancer-related defects occur, the G2/M checkpoint and its activation in response to DNA damage, and the spindle checkpoint.
Figures
References
-
- Amon A (1999). The spindle checkpoint. Curr. Op Gen Dev 9,69. - PubMed
-
- Baldin V, Cans C, Knibiehler M, Ducommun B (1997). Phosphorylation of human CDC25B phosphatase by CDK1‐cyclin A triggers its proteasome‐dependent degradation. J. Biol. Chem 272,32731. - PubMed
-
- Barth H, Hoffmann I, Klein S, Kaszkin M, Richards J, Kinzel V (1996). Role of cdc25‐C phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth factor and phorbolester. J. Cell Physiol. 168,589. - PubMed
-
- Bartkova J, Lukas J, Strauss M, Bartek J (1994). The PRAD‐1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J. Cancer 58,568. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
